Ke. Bowker et al., THE IN-VITRO ACTIVITY OF TROVAFLOXACIN AND 9 OTHER ANTIMICROBIALS AGAINST 413 ANAEROBIC-BACTERIA, Journal of antimicrobial chemotherapy, 38(2), 1996, pp. 271-281
The in-vitro activity of trovafloxacin and nine other antimicrobials w
as determined for 413 non copy anaerobic clinical isolates. Trovafloxa
cin was the most active quinolone tested with an MIC(90) of 0.5 mg/L a
gainst Gram-positive cocci (n = 75); MIC(90) of 4 mg/L against Gram-po
sitive bacilli (n = 151); MIC(90) of 0.5 mg/L for Gram-negative cocci
(n = 12) and MIC(90) of 1 mg/L for Gram-negative bacilli (n = 175). Ov
erall the MIC(90) of trovafloxacin was 1 mg/L which was equivalent to
co-amoxiclav and one dilution higher than that of imipenem. The other
seven comparators, including clindamycin and metronidazole, had higher
MIC(90) values than trovafloxacin. Trovafloxacin is likely to have cl
inically useful activity against anaerobes from human infection.